25 September 202419 September 2024 35 million euro for sustainable biotech: International consortium invests into Abolis Biotechnologies This funding will fuel the company’s expansion into global markets and accelerate its research and development efforts to bring innovative biomanufacturing and microbiome solutions to the market
35 Mio. Euro für nachhaltige Biotechnologie: Internationales Konsortium investiert in Abolis Biotechnologies Mit Hilfe dieser Finanzierung will das Unternehmen die Erschließung globaler Märkte vorantreiben und die Forschung und Entwicklung von innovativen Biomanufacturing- und Mikrobiom-Lösungen beschleunigen
28 May 202423 May 2024 HealthTech Bioactives Partners with Abolis for Sustainable Production of High-Value Polyphenols The initial phase of the partnership will focus on developing two high-value molecules with limited sourcing availability
27 August 202025 August 2020 An interview with Cyrille Pauthenier, Ceo of French biotech company Abolis This exclusive interview with Il Bioeconomista is with Cyrille Pauthenier, Ceo and co-founder of Abolis, an industrial biotech company located in France
25 November 201623 November 2016 SynBio is gearing up Synthetic Biology's large field of applications became apparent at the EFIB-conference in Glasgow, last October